Interaction of Spironolactone with Rat Skin Androgen Receptor

    Andrée Boisselle, F. T. Dionne, Roland R. Tremblay
    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that administering spironolactone or canrenone to castrated male rats significantly decreased the availability of cytoplasmic androgen receptor binding sites, suggesting canrenone mediates spironolactone's antiandrogenic effects in skin.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →